As U.S. News tweaks methodology, top four cancer hospitals remain unchanged from last year (1) MD Anderson, (2) MSK, (3) Mayo, (4) DFCI

Swim Across America grants $900,000 toward gene editing innovation

Joseph FraiettaPietro GenoveseSwim Across America, the nonprofit funding innovative clinical trials and patient-centered programs for cancer, awarded $450,000 grants to two of its beneficiaries, Alliance for Cancer Gene Therapy and Dana-Farber Cancer Institute, to support the work of novel gene and base editing techniques used in advanced cancer research, including targeted therapies, immunotherapies, and cellular therapies.

April 25, 2025

Vol.51 No.16

Clinical Roundup

Mayo Clinic researchers identify personalized approach to brain cancer monitoring

Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one of the most aggressive types of brain cancer.

April 25, 2025

Vol.51 No.16

In Brief

USC Norris opens Keck Medicine of USC–Newport Beach Radiation Oncology and Imaging center

USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has opened Keck Medicine of USC–Newport Beach Radiation Oncology and Imaging, a new radiation oncology and imaging center, at 4590 MacArthur Blvd. in Newport Beach, CA.

April 18, 2025

Vol.51 No.15

In Brief

Casirati, De Wolf, Persaud, Rehman awarded $260,000 research grants from DKMS

Gabriele Casirati, of Boston Children’s Hospital, Susan E. De Wolf, of Memorial Sloan Kettering Cancer Center, Stephen Persaud, of Washington University School of Medicine, and Abdur Rehman, of the University of Texas MD Anderson Cancer Center, were awarded DKMS’ research grant in honor of John A. Hansen.

April 11, 2025

Vol.51 No.14

Clinical Roundup

NK cells complexed with bispecific antibody yield high response rates in lymphoma

A novel cell therapy approach using cord blood-derived natural killer cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates for patients with refractory CD30-positive lymphomas, according to a new study from the University of Texas MD Anderson Cancer Center.

April 11, 2025

Vol.51 No.14

In Brief

MD Anderson breaks ground on new Houston-area cancer center

The University of Texas MD Anderson Cancer Center on March 31 broke ground on a new 470,000-square-foot facility in Sugar Land, bringing a range of cancer services closer to those living in Southwest Houston and the surrounding areas.

April 04, 2025

Vol.51 No.13

As U.S. News tweaks methodology, top four cancer hospitals remain unchanged from last year

(1) MD Anderson, (2) MSK, (3) Mayo, (4) DFCI

YOU MAY BE INTERESTED IN

Swim Across America grants $900,000 toward gene editing innovation

Mayo Clinic researchers identify personalized approach to brain cancer monitoring

USC Norris opens Keck Medicine of USC–Newport Beach Radiation Oncology and Imaging center

Casirati, De Wolf, Persaud, Rehman awarded $260,000 research grants from DKMS

NK cells complexed with bispecific antibody yield high response rates in lymphoma

MD Anderson breaks ground on new Houston-area cancer center

Renew today!

Subscriber content

Never miss an issue!

Login